B
Gilead Sciences, Inc. GILD
$120.02 -$0.45-0.37% NASDAQ
Recommendation
Prev Close
$120.02
Volume
4,804
Avg Vol (90D)
8,266,865
Market Cap
$148.92B
Dividend & Yield
$3.12(2.60%)
52-Week Range
$72.67 - $121.83
P/E (TTM)
23.96
EPS (TTM)
$5.01
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
5/2/2025 - MarketBeat
LGT Fund Management Co Ltd. Invests $2.77 Million in Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Russell Investments Group Ltd.
8/13/2025 - MarketBeat
Prudential PLC Sells 35,359 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Should You Invest in the iShares Biotechnology ETF (IBB)?
8/13/2025 - Zacks Investment Research
HighTower Advisors LLC Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Trillium Asset Management LLC Sells 40,297 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Independent Advisor Alliance Purchases 2,307 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Linscomb Wealth Inc.
8/13/2025 - MarketBeat
Cooper Financial Group Buys Shares of 2,342 Gilead Sciences, Inc. (NASDAQ:GILD)
8/13/2025 - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Boosted by Public Sector Pension Investment Board
8/12/2025 - Zolmax
Callan Family Office LLC Sells 4,149 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/12/2025 - Ticker Report
QQQI, QCOM, GILD, AMAT: ETF Inflow Alert
8/12/2025 - ETF Channel
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Boosted by Westpac Banking Corp
8/12/2025 - Ticker Report
Todd Asset Management LLC Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
8/12/2025 - MarketBeat
Longfellow Investment Management Co. LLC Sells 5,881 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/12/2025 - MarketBeat
Aigen Investment Management LP Buys New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)
8/12/2025 - MarketBeat
GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus
8/12/2025 - StockStory Articles
Earnings Season Is on Fire Who's Next to Beat?
8/11/2025 - InvestorPlace
Cypress Capital Group Decreases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
8/11/2025 - Ticker Report
2,075 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Keeler & Nadler Financial Planning & Wealth Management
8/11/2025 - Ticker Report
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
8/11/2025 - Zacks Investment Research
Gilead Sciences, Inc. (NASDAQ:GILD) Stake Boosted by Todd Asset Management LLC
8/11/2025 - Ticker Report
Connor Clark & Lunn Investment Management Ltd. Buys 27,172 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
8/11/2025 - MarketBeat
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
4/1/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$28.86B
EBITDA (TTM)
$13.78B
EBIT (TTM)
$11.01B
Net Income (TTM)
$6.31B
Balance Sheet
Total Assets (Q)
$55.72B
Total Debt (Q)
$24.95B
Total Liabilities (Q)
$36.13B
Book Value Per Share (Q)
$15.84
Cash Flow
Cash from Operations (TTM)
$9.87B
Cash from Investing (TTM)
-$3.47B
Cash from Financing (TTM)
-$4.11B
Net Change in Cash (TTM)
$2.37B
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
0.45
7-Day Total Return
4.81%
30-Day Total Return
7.42%
60-Day Total Return
17.92%
90-Day Total Return
7.54%
Year to Date Total Return
32.48%
1-Year Total Return
67.46%
2-Year Total Return
61.67%
3-Year Total Return
102.67%
5-Year Total Return
115.04%
52-week Low
Aug 13, 2024 - $72.67
52-week High
Aug 12, 2025 - $121.83
Valuation
Market Cap
$148.92B - Large Cap
Enterprise Value
$165.81B
Price/Sales (TTM)
5.22
Price/Book (Q)
7.58
Dividends and Shares
Shares Outstanding
1.26K
Dividend Per Share (Most Recent)
$0.79
Dividend Per Share (TTM)
$3.12
Corporate Info
Website
www.gilead.com
Phone Number
650 574 3000
Address
333 Lakeside Drive
Foster City, CA 94404
Country
United States
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The... more
NASDAQ 08/12/2025 4:00PM Eastern Quotes delayed